Lilly shares on track for worst day since 2021 after downbeat Zepbound sales forecast
Reuters was ahead of competitors with news that Eli Lilly's unscheduled trading update revealed lower-than-expected fourth-quarter sales of the weight-loss ...
Reuters was ahead of competitors with news that Eli Lilly's unscheduled trading update revealed lower-than-expected fourth-quarter sales of the weight-loss ...
Shares of Novo Nordisk dropped over 24% after disappointing results in a trial for its CagriSema weight loss drug, which ...
Copyright © 2024 News Wave
News Wave is not responsible for the content of external sites.
Copyright © 2024 News Wave
News Wave is not responsible for the content of external sites.